These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19617536)

  • 1. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion.
    Markovic DS; Vinnakota K; Chirasani S; Synowitz M; Raguet H; Stock K; Sliwa M; Lehmann S; Kälin R; van Rooijen N; Holmbeck K; Heppner FL; Kiwit J; Matyash V; Lehnardt S; Kaminska B; Glass R; Kettenmann H
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12530-5. PubMed ID: 19617536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
    Hu F; Dzaye O; Hahn A; Yu Y; Scavetta RJ; Dittmar G; Kaczmarek AK; Dunning KR; Ricciardelli C; Rinnenthal JL; Heppner FL; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    Neuro Oncol; 2015 Feb; 17(2):200-10. PubMed ID: 25452390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.
    Vinnakota K; Hu F; Ku MC; Georgieva PB; Szulzewsky F; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Lehnardt S; Hanisch UK; Synowitz M; Markovic D; Wolf SA; Glass R; Kettenmann H
    Neuro Oncol; 2013 Nov; 15(11):1457-68. PubMed ID: 24014382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.
    Hu F; Ku MC; Markovic D; Dzaye O; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    Int J Cancer; 2014 Dec; 135(11):2569-78. PubMed ID: 24752463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression.
    Yongjun Y; Shuyun H; Lei C; Xiangrong C; Zhilin Y; Yiquan K
    J Neuroimmunol; 2013 Jul; 260(1-2):1-8. PubMed ID: 23707077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression.
    Markovic DS; Vinnakota K; van Rooijen N; Kiwit J; Synowitz M; Glass R; Kettenmann H
    Brain Behav Immun; 2011 May; 25(4):624-8. PubMed ID: 21324352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PKC-α in NF-κB-MT1-MMP-mediated activation of proMMP-2 by TNF-α in pulmonary artery smooth muscle cells.
    Roy S; Chakraborti T; Chowdhury A; Chakraborti S
    J Biochem; 2013 Mar; 153(3):289-302. PubMed ID: 23266860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.
    Guo P; Imanishi Y; Cackowski FC; Jarzynka MJ; Tao HQ; Nishikawa R; Hirose T; Hu B; Cheng SY
    Am J Pathol; 2005 Mar; 166(3):877-90. PubMed ID: 15743799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cell line-derived neurotrophic factor increases matrix metallopeptidase 9 and 14 expression in microglia and promotes microglia-mediated glioma progression.
    Huang Y; Zhang B; Haneke H; Haage V; Lubas M; Yuan Y; Xia P; Motta E; Nanvuma C; Dzaye O; Hu F; Kettenmann H
    J Neurosci Res; 2021 Apr; 99(4):1048-1063. PubMed ID: 33404121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
    Onguchi T; Han KY; Chang JH; Azar DT
    Am J Pathol; 2009 Apr; 174(4):1564-71. PubMed ID: 19264910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
    McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
    Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas.
    Gabrusiewicz K; Ellert-Miklaszewska A; Lipko M; Sielska M; Frankowska M; Kaminska B
    PLoS One; 2011; 6(8):e23902. PubMed ID: 21901144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
    Belkaid A; Fortier S; Cao J; Annabi B
    Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells.
    Annabi B; Laflamme C; Sina A; Lachambre MP; Béliveau R
    J Neuroinflammation; 2009 Mar; 6():8. PubMed ID: 19272160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
    Sakr M; Takino T; Sabit H; Nakada M; Li Z; Sato H
    Gene; 2016 Aug; 587(2):155-62. PubMed ID: 27154818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.
    Ingvarsen S; Porse A; Erpicum C; Maertens L; Jürgensen HJ; Madsen DH; Melander MC; Gårdsvoll H; Høyer-Hansen G; Noel A; Holmbeck K; Engelholm LH; Behrendt N
    J Biol Chem; 2013 Apr; 288(15):10195-204. PubMed ID: 23413031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
    D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
    J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.